361 related articles for article (PubMed ID: 37131230)
1. The synergistic effect of the triglyceride-glucose index and serum uric acid on the prediction of major adverse cardiovascular events after coronary artery bypass grafting: a multicenter retrospective cohort study.
Wu Z; Cheng C; Sun X; Wang J; Guo D; Chen S; Zhang Y; Liu X; Liu L; Zhang C; Yang J
Cardiovasc Diabetol; 2023 May; 22(1):103. PubMed ID: 37131230
[TBL] [Abstract][Full Text] [Related]
2. Triglyceride-glucose index in the prediction of adverse cardiovascular events in patients without diabetes mellitus after coronary artery bypass grafting: a multicenter retrospective cohort study.
Wu Z; Xie L; Guo D; Chen S; Liu X; Sun X; Wang J; Zhang Y; Liu L; Cui H; Zang D; Yang J
Cardiovasc Diabetol; 2023 Aug; 22(1):230. PubMed ID: 37649025
[TBL] [Abstract][Full Text] [Related]
3. Combination of the triglyceride-glucose index and EuroSCORE II improves the prediction of long-term adverse outcomes in patients undergoing coronary artery bypass grafting.
Wu Z; Guo D; Chen S; Sun X; Zhang Y; Liu X; Liu L; Lin Z; Yang J
Diabetes Metab Res Rev; 2023 Nov; 39(8):e3710. PubMed ID: 37537868
[TBL] [Abstract][Full Text] [Related]
4. Triglyceride-glucose index in the prediction of adverse cardiovascular events in patients with premature coronary artery disease: a retrospective cohort study.
Wu Z; Liu L; Wang W; Cui H; Zhang Y; Xu J; Zhang W; Zheng T; Yang J
Cardiovasc Diabetol; 2022 Jul; 21(1):142. PubMed ID: 35906587
[TBL] [Abstract][Full Text] [Related]
5. Adjustment of the GRACE score by the triglyceride glucose index improves the prediction of clinical outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
Xiong S; Chen Q; Chen X; Hou J; Chen Y; Long Y; Yang S; Qi L; Su H; Huang W; Liu H; Zhang Z; Cai L
Cardiovasc Diabetol; 2022 Aug; 21(1):145. PubMed ID: 35932019
[TBL] [Abstract][Full Text] [Related]
6. A synergistic effect of the triglyceride-glucose index and the residual SYNTAX score on the prediction of intermediate-term major adverse cardiac events in patients with type 2 diabetes mellitus undergoing percutaneous coronary intervention.
Xiong S; Chen Q; Zhang Z; Chen Y; Hou J; Cui C; Cheng L; Su H; Long Y; Yang S; Qi L; Chen X; Liu H; Cai L
Cardiovasc Diabetol; 2022 Jun; 21(1):115. PubMed ID: 35751060
[TBL] [Abstract][Full Text] [Related]
7. The triglyceride-glucose index predicts 1-year major adverse cardiovascular events in end-stage renal disease patients with coronary artery disease.
Xie E; Ye Z; Wu Y; Zhao X; Li Y; Shen N; Gao Y; Zheng J
Cardiovasc Diabetol; 2023 Oct; 22(1):292. PubMed ID: 37891651
[TBL] [Abstract][Full Text] [Related]
8. Triglyceride-glucose index in the prediction of major adverse cardiovascular events in patients with type 2 diabetes mellitus after coronary artery bypass surgery: A retrospective cohort study.
Zhang H; Chong H; Li Z; Li K; Zhang B; Xue Y; Wang D
Front Endocrinol (Lausanne); 2022; 13():1015747. PubMed ID: 36339437
[TBL] [Abstract][Full Text] [Related]
9. Triglyceride-glucose index predicts adverse cardiovascular events in patients with diabetes and acute coronary syndrome.
Wang L; Cong HL; Zhang JX; Hu YC; Wei A; Zhang YY; Yang H; Ren LB; Qi W; Li WY; Zhang R; Xu JH
Cardiovasc Diabetol; 2020 Jun; 19(1):80. PubMed ID: 32534586
[TBL] [Abstract][Full Text] [Related]
10. Triglyceride-glucose index is associated with poor prognosis in acute coronary syndrome patients with prior coronary artery bypass grafting undergoing percutaneous coronary intervention.
Dong S; Zhao Z; Huang X; Ma M; Yang Z; Fan C; Han H; Wang Z; Shi D; Zhou Y
Cardiovasc Diabetol; 2023 Oct; 22(1):286. PubMed ID: 37891647
[TBL] [Abstract][Full Text] [Related]
11. Triglyceride-glucose index is a predictive index of hyperuricemia events in elderly patients with hypertension: a cross-sectional study.
Dong J; Yang H; Zhang Y; Hu Q
Clin Exp Hypertens; 2022 Jan; 44(1):34-39. PubMed ID: 34633263
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of triglyceride-glucose index in patients with chronic coronary syndrome undergoing percutaneous coronary intervention.
Tao S; Yu L; Li J; Xie Z; Huang L; Yang D; Tan Y; Zhang W; Huang X; Xue T
Cardiovasc Diabetol; 2023 Nov; 22(1):322. PubMed ID: 38017540
[TBL] [Abstract][Full Text] [Related]
13. Associations of triglyceride-glucose index with hyperuricemia among Royal Thai Army personnel.
Lertsakulbunlue S; Sangkool T; Bhuriveth V; Mungthin M; Rangsin R; Kantiwong A; Sakboonyarat B
BMC Endocr Disord; 2024 Feb; 24(1):17. PubMed ID: 38297286
[TBL] [Abstract][Full Text] [Related]
14. Triglyceride-glucose index is associated with recurrent revascularization in patients with type 2 diabetes mellitus after percutaneous coronary intervention.
Chen Q; Xiong S; Zhang Z; Yu X; Chen Y; Ye T; Yang S; Qi L; Chen X; Liu H; Zheng J; Cai L
Cardiovasc Diabetol; 2023 Oct; 22(1):284. PubMed ID: 37865753
[TBL] [Abstract][Full Text] [Related]
15. Impacts of triglyceride-glucose index on prognosis of patients with type 2 diabetes mellitus and non-ST-segment elevation acute coronary syndrome: results from an observational cohort study in China.
Zhao Q; Zhang TY; Cheng YJ; Ma Y; Xu YK; Yang JQ; Zhou YJ
Cardiovasc Diabetol; 2020 Jul; 19(1):108. PubMed ID: 32641127
[TBL] [Abstract][Full Text] [Related]
16. Addition of TyG index to the GRACE score improves prediction of adverse cardiovascular outcomes in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention: A retrospective study.
Pang S; Miao G; Zhou Y; Du Y; Rui Z; Zhao X
Front Cardiovasc Med; 2022; 9():957626. PubMed ID: 36093151
[TBL] [Abstract][Full Text] [Related]
17. Triglyceride-Glucose Index as a Surrogate Marker of Insulin Resistance for Predicting Cardiovascular Outcomes in Nondiabetic Patients with Non-ST-Segment Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.
Zhao Q; Zhang TY; Cheng YJ; Ma Y; Xu YK; Yang JQ; Zhou YJ
J Atheroscler Thromb; 2021 Nov; 28(11):1175-1194. PubMed ID: 33191314
[TBL] [Abstract][Full Text] [Related]
18. An elevated triglyceride-glucose index predicts adverse outcomes and interacts with the treatment strategy in patients with three-vessel disease.
Zhang Y; Zhang C; Jiang L; Xu L; Tian J; Zhao X; Wang D; Zhang Y; Sun K; Zhang C; Xu B; Zhao W; Hui R; Gao R; Wang J; Feng X; Yuan J; Song L
Cardiovasc Diabetol; 2023 Dec; 22(1):333. PubMed ID: 38057801
[TBL] [Abstract][Full Text] [Related]
19. Association of the cumulative triglyceride-glucose index with major adverse cardiovascular events in patients with type 2 diabetes.
Tai S; Fu L; Zhang N; Yang R; Zhou Y; Xing Z; Wang Y; Zhou S
Cardiovasc Diabetol; 2022 Aug; 21(1):161. PubMed ID: 35999546
[TBL] [Abstract][Full Text] [Related]
20. Impact of triglyceride-glucose index on long-term cardiovascular outcomes in patients with myocardial infarction with nonobstructive coronary arteries.
Gao S; Ma W; Huang S; Lin X; Yu M
Nutr Metab Cardiovasc Dis; 2021 Oct; 31(11):3184-3192. PubMed ID: 34511291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
